跳至主要内容
临床试验/ISRCTN12605216
ISRCTN12605216已完成未知

The REMEDI study ? Rapid Examination of Malaria and Evaluation of Diagnostic Information

niversity of California, San Francisco (USA)0 个研究点目标入组 1,500 人开始时间: 2013年10月18日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,500

研究概览

简要总结

  1. 2015 results in https://www.ncbi.nlm.nih.gov/pubmed/25877471 (added 21/01/2019) 2. 2016 results in https://www.ncbi.nlm.nih.gov/pubmed/27315831 (added 21/01/2019)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adult aged over 17 years and having purchased malaria drugs for either him/herself or an accompanying minor at an enrolled study site
  • 2. Customers must be willing to be assigned to any of the study intervention groups
  • 3. Participating drugs shops must sell at least one type of antimalarial drug

排除标准

  • 1. Pregnant women who are seeking malaria treatment for herself are excluded because the recommended treatment for malaria is a different drug regimen than one than the study can provide
  • 2. Any individual seeking treatment for illnesses other than malaria
  • 3. Any adult who is purchasing malaria for a minor and the minor is not present at the time of enrollment
  • 4. Because the study involves a follow-up survey conducted via phone, participants who cannot provide at least one phone number at which they can be reached are excluded
  • 5. Drug shops that do not sell antimalarial drugs are excluded

研究者

发起方
niversity of California, San Francisco (USA)

相似试验